Therapeutic Vaccination With Recombinant Adenovirus Reduces Splenic Parasite Burden in Experimental Visceral Leishmaniasis

Visceral leishmaniasis: immunology and prospects for a vaccine

(2011) P.M. Kaye et al.   CLINICAL MICROBIOLOGY AND INFECTION

Vaccines for the Leishmaniases: Proposals for a Research Agenda

(2011) et al.   PLoS Neglected Tropical Diseases

Single Dose Novel Salmonella Vaccine Enhances Resistance against Visceralizing L. major and L. donovani Infection in Susceptible BALB/c Mice

(2011) Juliane Schroeder et al.   PLoS Neglected Tropical Diseases

Evaluation of Ex Vivo Human Immune Response against Candidate Antigens for a Visceral Leishmaniasis Vaccine

(2010) Rajiv Kumar et al.   AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE

Immunomodulators: use in combined therapy against leishmaniasis

(2010) Jane E Dalton et al.   Expert Review of Anti-Infective Therapy

Prime-boost vectored malaria vaccines: Progress and prospects

(2010) Adrian V. S. Hill et al.   Human vaccines & immunotherapeutics

Inhibition of receptor tyrosine kinases restores immunocompetence and improves immune-dependent chemotherapy against experimental leishmaniasis in mice

(2010) Jane E. Dalton et al.   JOURNAL OF CLINICAL INVESTIGATION

IL-10 production differentially influences the magnitude, quality, and protective capacity of Th1 responses depending on the vaccine platform

(2010) Patricia A. Darrah et al.   JOURNAL OF EXPERIMENTAL MEDICINE

Combination therapy for visceral leishmaniasis

(2010) Johan van Griensven et al.   LANCET INFECTIOUS DISEASES

Long-Term Thermostabilization of Live Poxviral and Adenoviral Vaccine Vectors at Supraphysiological Temperatures in Carbohydrate Glass

(2010) R. Alcock et al.   Science Translational Medicine

A clinical trial to evaluate the safety and immunogenicity of the LEISH-F1+MPL-SE vaccine when used in combination with meglumine antimoniate for the treatment of cutaneous leishmaniasis

(2010) Evaldo Nascimento et al.   VACCINE

Treatment of canine visceral leishmaniasis by the vaccine Leish-111f+MPL-SE

(2010) Joelma Trigo et al.   VACCINE

A replication defective recombinant Ad5 vaccine expressing Ebola virus GP is safe and immunogenic in healthy adults

(2010) J.E. Ledgerwood et al.   VACCINE

Tailoring subunit vaccine immunogenicity: Maximizing antibody and T cell responses by using combinations of adenovirus, poxvirus and protein-adjuvant vaccines against Plasmodium falciparum MSP1

(2010) Alexander D. Douglas et al.   VACCINE

Overview of STEP and Phambili trial results: two phase IIb test-of-concept studies investigating the efficacy of MRK adenovirus type 5 gag/pol/nef subtype B HIV vaccine

(2010) Glenda Gray et al.   Current Opinion in HIV and AIDS

Leishmania-Specific Surface Antigens Show Sub-Genus Sequence Variation and Immune Recognition

(2010) Daniel P. Depledge et al.   PLoS Neglected Tropical Diseases

Innate Killing of Leishmania donovani by Macrophages of the Splenic Marginal Zone Requires IRF-7

(2010) Rebecca Phillips et al.   PLoS Pathogens

Immunotherapy as a strategy for treatment of leishmaniasis: a review of the literature

(2009) Ifeoma Okwor et al.   Immunotherapy

Immunological stimulation for the treatment of leishmaniasis: a modality worthy of serious consideration

(2009) Ahmed Mudawi Musa et al.   TRANSACTIONS OF THE ROYAL SOCIETY OF TROPICAL MEDICINE AND HYGIENE

First-Line Therapy for Human Cutaneous Leishmaniasis in Peru Using the TLR7 Agonist Imiquimod in Combination with Pentavalent Antimony

(2009) Cesar Miranda-Verastegui et al.   PLoS Neglected Tropical Diseases

B7-H1 Blockade Increases Survival of Dysfunctional CD8+ T Cells and Confers Protection against Leishmania donovani Infections

(2009) Trupti Joshi et al.   PLoS Pathogens

Single-dose immunogenicity and protective efficacy of simian adenoviral vectors againstPlasmodium berghei

(2008) Arturo Reyes-Sandoval et al.   EUROPEAN JOURNAL OF IMMUNOLOGY

The Host Response to Adenovirus, Helper-dependent Adenovirus, and Adeno-associated Virus in Mouse Liver

(2008) Anton P McCaffrey et al.   MOLECULAR THERAPY